It has been 3,912 days since my first purchase of AVXL, long before I was diagnosed with Mild Cognitive Impairment (MCI). Way back then, I projected the earliest possible FDA approval could come in 2021, with it being likely to come in 2023, and possible that it would take several years beyond that. This was my private analysis, which I think I did not share publicly until now.
My projection still seems reasonable to me, with the simple adjustment to 2022 for the earliest possible FDA approval, and keeping 2023 as the most likely year.